View in EDS HTML Full Text PDF Full Text

Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.

Saved in:
Bibliographic Details
Title: Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.
Authors: Perdigoto AL; Division of Endocrinology, Department of Internal Medicine, Yale University, New Haven, CT, USA., Preston-Hurlburt P; Department of Immunobiology, Yale University, 300 George St, 353E, New Haven, CT, 06520, USA., Clark P; Department of Immunobiology, Yale University, 300 George St, 353E, New Haven, CT, 06520, USA., Long SA; Benaroya Research Institute at Virginia Mason, Seattle, WA, USA., Linsley PS; Benaroya Research Institute at Virginia Mason, Seattle, WA, USA., Harris KM; Immune Tolerance Network, Biomarker & Discovery Research, Bethesda, MD, USA., Gitelman SE; Division of Pediatric Endocrinology and Diabetes Center, University of California San Francisco, San Francisco, CA, USA., Greenbaum CJ; Benaroya Research Institute at Virginia Mason, Seattle, WA, USA., Gottlieb PA; Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Hagopian W; Pacific Northwest Research Institute, Seattle, WA, USA., Woodwyk A; Division of Epidemiology or Biostatistics, Western Michigan University, Kalamazoo, MI, USA., Dziura J; Department of Emergency Medicine, Yale University, New Haven, CT, USA., Herold KC; Department of Immunobiology, Yale University, 300 George St, 353E, New Haven, CT, 06520, USA. kevan.herold@yale.edu.
Corporate Authors: Immune Tolerance Network
Source: Diabetologia [Diabetologia] 2019 Apr; Vol. 62 (4), pp. 655-664. Date of Electronic Publication: 2018 Dec 19.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30569273
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Perdigoto+AL%22">Perdigoto AL</searchLink>; Division of Endocrinology, Department of Internal Medicine, Yale University, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Preston-Hurlburt+P%22">Preston-Hurlburt P</searchLink>; Department of Immunobiology, Yale University, 300 George St, 353E, New Haven, CT, 06520, USA.<br /><searchLink fieldCode="AU" term="%22Clark+P%22">Clark P</searchLink>; Department of Immunobiology, Yale University, 300 George St, 353E, New Haven, CT, 06520, USA.<br /><searchLink fieldCode="AU" term="%22Long+SA%22">Long SA</searchLink>; Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Linsley+PS%22">Linsley PS</searchLink>; Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Harris+KM%22">Harris KM</searchLink>; Immune Tolerance Network, Biomarker & Discovery Research, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gitelman+SE%22">Gitelman SE</searchLink>; Division of Pediatric Endocrinology and Diabetes Center, University of California San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Greenbaum+CJ%22">Greenbaum CJ</searchLink>; Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Gottlieb+PA%22">Gottlieb PA</searchLink>; Barbara Davis Center for Childhood Diabetes, University of Colorado School of Medicine, Aurora, CO, USA.<br /><searchLink fieldCode="AU" term="%22Hagopian+W%22">Hagopian W</searchLink>; Pacific Northwest Research Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Woodwyk+A%22">Woodwyk A</searchLink>; Division of Epidemiology or Biostatistics, Western Michigan University, Kalamazoo, MI, USA.<br /><searchLink fieldCode="AU" term="%22Dziura+J%22">Dziura J</searchLink>; Department of Emergency Medicine, Yale University, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Herold+KC%22">Herold KC</searchLink>; Department of Immunobiology, Yale University, 300 George St, 353E, New Haven, CT, 06520, USA. kevan.herold@yale.edu.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Immune+Tolerance+Network%22">Immune Tolerance Network</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220006777%22">Diabetologia</searchLink> [Diabetologia] 2019 Apr; Vol. 62 (4), pp. 655-664. <i>Date of Electronic Publication: </i>2018 Dec 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>0006777 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0428 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220012186X%22">0012186X </searchLink><i>NLM ISO Abbreviation: </i>Diabetologia <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30569273
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00125-018-4786-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 655
    Titles:
      – TitleFull: Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Perdigoto AL
      – PersonEntity:
          Name:
            NameFull: Preston-Hurlburt P
      – PersonEntity:
          Name:
            NameFull: Clark P
      – PersonEntity:
          Name:
            NameFull: Long SA
      – PersonEntity:
          Name:
            NameFull: Linsley PS
      – PersonEntity:
          Name:
            NameFull: Harris KM
      – PersonEntity:
          Name:
            NameFull: Gitelman SE
      – PersonEntity:
          Name:
            NameFull: Greenbaum CJ
      – PersonEntity:
          Name:
            NameFull: Gottlieb PA
      – PersonEntity:
          Name:
            NameFull: Hagopian W
      – PersonEntity:
          Name:
            NameFull: Woodwyk A
      – PersonEntity:
          Name:
            NameFull: Dziura J
      – PersonEntity:
          Name:
            NameFull: Herold KC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2019 Apr
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0428
          Numbering:
            – Type: volume
              Value: 62
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Diabetologia
              Type: main
ResultId 1